Nanobodies dismantle post‐pyroptotic ASC specks and counteract inflammation <i>in vivo</i>-Reference-Cited by-同舟云学术

Nanobodies dismantle post‐pyroptotic ASC specks and counteract inflammation in vivo

Published:2022-04-19 Issue:6 Volume:14 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Bertheloot Damien¹^ORCID,Wanderley Carlos WS²³,Schneider Ayda H²³,Schiffelers Lisa DJ¹^ORCID,Wuerth Jennifer D¹^ORCID,Tödtmann Jan MP⁴^ORCID,Maasewerd Salie¹^ORCID,Hawwari Ibrahim¹,Duthie Fraser¹,Rohland Cornelia¹,Ribeiro Lucas S¹^ORCID,Jenster Lea‐Marie¹^ORCID,Rosero Nathalia¹,Tesfamariam Yonas M¹^ORCID,Cunha Fernando Q²³,Schmidt Florian I¹⁴^ORCID,Franklin Bernardo S¹^ORCID

Affiliation:

1. Institute of Innate Immunity Medical Faculty University of Bonn Bonn Germany

2. Center for Research in Inflammatory Diseases (CRID) Ribeirao Preto Medical School University of Sao Paulo Sao Paulo Brazil

3. Department of Pharmacology Ribeirao Preto Medical School University of Sao Paulo Sao Paulo Brazil

4. Core Facility Nanobodies Medical Faculty University of Bonn Bonn Germany

Funder

H2020 European Research Council

Deutsche Forschungsgemeinschaft

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202115415

Reference74 articles.

1. Evidence of inflammasome activation and formation of monocyte-derived ASC specks in HIV-1 positive patients

2. Intracellular Expression of Camelid Single-Domain Antibodies Specific for Influenza Virus Nucleoprotein Uncovers Distinct Features of Its Nuclear Localization

3. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response

4. Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort study

5. BenH(2019)Novartis bets $1.6bn on inflammasome‐focused biotech.Outsourcing‐Pharmahttps://www.outsourcing‐pharma.com/Article/2019/04/01/Novartis‐acquires‐IFM‐Tre‐for‐1.6bn

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammasome components as new therapeutic targets in inflammatory disease;Nature Reviews Immunology;2024-09-09

2. Therapeutic Targets in Innate Immunity to Tackle Alzheimer’s Disease;Cells;2024-08-26

3. NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies;Frontiers in Pharmacology;2024-07-31

4. Anti-Inflammatory Efficacy of Nanobody Specific to β-Glucan on a Fungal Cell Wall in a Murine Model of Fungal Keratitis;ACS Infectious Diseases;2024-07-31

5. “Cruising together”—ASC specks and SAA, a perfect match in chronic inflammation;EMBO Molecular Medicine;2024-07-30